2-Pyridinecarboxamide, N-[6-(1-hydroxy-1-methylethyl)-2-[2-(methylsulfonyl)ethyl]-2H-indazol-5-yl]-6-(trifluoromethyl)-
- Product Name
- 2-Pyridinecarboxamide, N-[6-(1-hydroxy-1-methylethyl)-2-[2-(methylsulfonyl)ethyl]-2H-indazol-5-yl]-6-(trifluoromethyl)-
- CAS No.
- 1931994-81-8
- Chemical Name
- 2-Pyridinecarboxamide, N-[6-(1-hydroxy-1-methylethyl)-2-[2-(methylsulfonyl)ethyl]-2H-indazol-5-yl]-6-(trifluoromethyl)-
- Synonyms
- BAY-845;BAY-1834845;Zabedosertib;Zabedosertib, 10 mM in DMSO;N-(6-(2-Hydroxypropan-2-yl)-2-(2-(methylsulfonyl)ethyl)-2H-indazol-5-yl)-6-(trifluoromethyl)picolinamide;N-[6-(2-Hydroxy-2-propyl)-2-[2-(methylsulfonyl)ethyl]-2H-indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(1-hydroxy-1-methyl-ethyl)-2-(2-methylsulfonylethyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;2-Pyridinecarboxamide, N-[6-(1-hydroxy-1-methylethyl)-2-[2-(methylsulfonyl)ethyl]-2H-indazol-5-yl]-6-(trifluoromethyl)-
- CBNumber
- CB38237502
- Molecular Formula
- C20H21F3N4O4S
- Formula Weight
- 470.47
- MOL File
- 1931994-81-8.mol
2-Pyridinecarboxamide, N-[6-(1-hydroxy-1-methylethyl)-2-[2-(methylsulfonyl)ethyl]-2H-indazol-5-yl]-6-(trifluoromethyl)- Property
- Boiling point:
- 620.7±55.0 °C(Predicted)
- Density
- 1.44±0.1 g/cm3(Predicted)
- storage temp.
- Store at -20°C
- solubility
- DMSO : 125 mg/mL (265.69 mM; ultrasonic and warming and heat to 60°C)
- pka
- 11.53±0.43(Predicted)
- form
- Solid
- color
- White to off-white
2-Pyridinecarboxamide, N-[6-(1-hydroxy-1-methylethyl)-2-[2-(methylsulfonyl)ethyl]-2H-indazol-5-yl]-6-(trifluoromethyl)- Chemical Properties,Usage,Production
Uses
Zabedosertib (BAY 1834845) is a selective, orally active IRAK4 inhibitor with immunomodulatory potential, IC50 is 3.55 nM. IRAK4 is a protein kinase involved in signaling innate immune responses from Toll-like receptors[1]. Zabedosertib exhibits anti-inflammatory property against IL-β, LPS (HY-D1056) and Imiquimod (HY-B1080) induced inflammation[2].
in vivo
Zabedosertib (150 mg/kg, p.o., twice) prevents lung injury and reduces inflammation in LPS induced ARDS in BALB/c mice[2].
Zabedosertib inhibits IL-β(p.o., 40-80 mg/kg, once), LPS (p.o., 10-40 mg/kg, once) and Imiquimod (p.o., 15-150 mg/kg, twice daily for 7 days) induced inflammation[3].
Zabedosertib has a Pharmacokinetic profile in rats[3]:
Pharmacokinetic Analysis of Zabedosertib in rats[1]
| species | Doseiv (mg/kg) | AUCnorm,iv (kg·h/L) | CLblood (L/h/kg) | Vss (L/kg) | T1/2,iv (h) | Dosepo(mg/kg) | AUCnorm,po (kg·h/L)) | Cmax,norm (kg/L) | Tmax (h) | F (%) |
| rat | 0.5 | 5.6 | 0.24 | 0.92 | 4.2 | 2.0 | 5.3 | 0.55 | 4.0 | 94 |
| dog | 0.5 | 15 | 0.088 | 1.6 | 17 | 1.0 | 15 | 0.57 | 2.0 | 104 |
| Animal Model: | LPS induced ARDS in BLAB/c mice[2] |
| Dosage: | 150 mg/kg |
| Administration: | p.o., twice (30 min before and 6 h after LPS-injection or 4 h and 12 h after LPS-injection) |
| Result: | Decreased inflammatory cells infiltration. Combination of Zabedosertib and DEX ( HY-14648) decreased T-cells, monocytes and macrophages. |
| Animal Model: | BALB/c mice[3] |
| Dosage: | IL-β:40-80 mg/kg, LPS: 10-40 mg/kg, Imiquimod: 15-150 mg/kg |
| Administration: | oral gavage, IL-β: once, LPS: once, Imiquimod: twice daily for 7 days |
| Result: | Inhibited IL-β, LPS induced inflammation in a dose-dependent manner. Inhibited Imiquimod induced inflammation. |
IC 50
IRAK4: 3.55 nM (IC50)
References
[1] Bothe, Ulrich; Siebenreicher, Holger; Schmidt, Nicole; Nubbemeyer, Reinhard; Boemer, Ulf; Guenther, Judith; Steuber, Holger; Lange, Martin; Stegmann, Christian; Sutter, Andreas; et al.New substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said new substituted indazoles, and use of said new substituted indazoles to produce drugs.WO2016083433A1
[2] Li Q, et al., Oral IRAK4 inhibitor BAY-1834845 prevents acute respiratory distress syndrome. Biomed Pharmacother. 2022 Sep;153:113459. DOI:10.1016/j.biopha.2022.113459
[3] Bothe U, et al., Discovery of IRAK4 Inhibitors BAY1834845 (Zabedosertib) and BAY1830839. J Med Chem. 2024 Jan 25;67(2):1225-1242. DOI:10.1021/acs.jmedchem.3c01714
2-Pyridinecarboxamide, N-[6-(1-hydroxy-1-methylethyl)-2-[2-(methylsulfonyl)ethyl]-2H-indazol-5-yl]-6-(trifluoromethyl)- Preparation Products And Raw materials
Raw materials
Preparation Products
2-Pyridinecarboxamide, N-[6-(1-hydroxy-1-methylethyl)-2-[2-(methylsulfonyl)ethyl]-2H-indazol-5-yl]-6-(trifluoromethyl)- Suppliers
- Tel
- +86 13524779951; 13524779951
- Fax
- QQ: 2075692521
- 2075692521@qq.com
- Country
- China
- ProdList
- 310
- Advantage
- 55
- Tel
- 526763801 13301653310
- Fax
- +86-21-51619052
- 526763801@qq.com
- Country
- China
- ProdList
- 9273
- Advantage
- 55
- Tel
- 021-65675885 18964387627
- Fax
- 021-65675885
- info@efebio.com
- Country
- China
- ProdList
- 9803
- Advantage
- 58
- Tel
- 177-54423994 17754423994
- Fax
- QQ:2853530913
- 2853530910@QQ.com
- Country
- China
- ProdList
- 8000
- Advantage
- 62
- Tel
- 021-QQ：65489617 15618227136
- Fax
- 21-5161 9052
- Sales@ATKchemical.com
- Country
- China
- ProdList
- 9119
- Advantage
- 58
- Tel
- 0512-65816829 18662214788
- Fax
- 0512-65816829
- info@rovathin.com.cn
- Country
- China
- ProdList
- 9987
- Advantage
- 58
- Tel
- +1-781-999-5354; +17819995354
- marketing@targetmol.com
- Country
- United States
- ProdList
- 32435
- Advantage
- 58
- Tel
- 0512-0512-13601744364 13601744364
- chemsharker@126.com
- Country
- China
- ProdList
- 1010
- Advantage
- 58
- Tel
- 13180081292 13180081292
- contact@wetogethermed.com
- Country
- China
- ProdList
- 7947
- Advantage
- 58
- Tel
- 027-59101668 19945030958
- Fax
- 027-59101668
- 2881924765@qq.com
- Country
- China
- ProdList
- 7941
- Advantage
- 58